Table 2.
Descriptive Statistics for Categorical Variables. Each cell contains the number and % in each of the variable’s subgroups
| Variable | Group1 | Group2 | Group3 | Total | P-Value | |
|---|---|---|---|---|---|---|
| Gender | Female | 12 (60%) | 9 (45%) | 6 (30%) | 27 (45%) | 0.184 |
| Male | 8 (40%) | 11 (55%) | 14 (70%) | 33 (55%) | ||
| Race | Asian | 0 (0%) | 1 (5%) | 1 (5%) | 2 (3%) | 0.201 |
| Black | 1 (5%) | 2 (10%) | 5 (25%) | 8 (13%) | ||
| Mixed | 1 (5%) | 4 (20%) | 3 (15%) | 8 (13%) | ||
| Other | 0 (0%) | 1 (5%) | 0 (0%) | 1 (2%) | ||
| White | 18 (90%) | 12 (60%) | 11 (55%) | 41 (68%) | ||
| Stage (ISS) | I | 7 (35%) | 2 (10%) | 8 (40%) | 17 (28%) | 0.401 |
| II | 4 (20%) | 5 (25%) | 5 (25%) | 14 (23%) | ||
| III | 5 (25%) | 6 (30%) | 3 (15%) | 14 (23%) | ||
| Unknown | 4 (20%) | 7 (35%) | 4 (20%) | 15 (25%) | ||
| High Risk Cytogenetics | No | 19 (95%) | 16 (80%) | 13 (65%) | 51 (85%) | 0.166 |
| Yes | 1 (5%) | 4 (20%) | 4 (20%) | 9 (15%) | ||
| Disease Status at Transplant | 1st remission | 14 (70%) | 14 (70%) | 17 (85%) | 45 (75%) | 0.499 |
| Relapsed | 6 (30%) | 6 (30%) | 3 (15%) | 15 (25%) | ||
| Response to last Rx before Transplant | PD | 3 (15%) | 2 (10%) | 0 (0%) | 5 (8%) | 0.292 |
| PR/VGPR | 16 (80%) | 14 (70%) | 18 (90%) | 48 (80%) | ||
| SD | 1 (5%) | 4 (20%) | 2 (10%) | 7 (12%) | ||
| BM Plasma Cells | >10% | 6 (30%) | 6 (30%) | 4 (20%) | 16 (27%) | 0.99 |
| <10% | 14(70%) | 14 (70%) | 16 (80%) | 43 (73%) |
ISS: International Staging System, PD: Progressive disease, PR: Partial response VGPR: Very good partial response, SD: Stable disease, BM: bone marrow Rx: treatment